Abbott and Zeiss join forces, Valeant and Allergan continue to battle

Are a significant number of users risking retinal damage?

Alimera and Allergan benefit from new FDA approvals, Allergan continues to battle Valeant, and Oculentis sues Lenstec over IOL patent infringement

Survey shows UK-based GPs lack confidence in their ability to diagnose ocular disease

Ophthalmologists would change recommendations if treating themselves

Transgenic mouse studies have revealed a signaling pathway that’s central to Schlemm’s canal formation

Would you recommend vision correction surgery solely to facilitate your patient’s enjoyment of virtual reality technology?

Are people with certain genotypes actively harmed by AREDS supplementation, accelerating AMD?

Can a new implantable microfluidic sensor put IOP tracking in the hands – or rather eyes – of patients with glaucoma?

An overstretched UK hospital that subcontracted cataract surgery is faced with a 48.3 percent complication rate. Who foots the legal bill?